메뉴 건너뛰기




Volumn 71, Issue 5, 2014, Pages 394-402

Quetiapine for insomnia: A review of the literature

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

EID: 84906064195     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130221     Document Type: Review
Times cited : (95)

References (42)
  • 1
    • 34548487159 scopus 로고    scopus 로고
    • Insomnia: Definition, prevalence, etiology, and consequences
    • Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007; 3(suppl):S7-10.
    • (2007) J Clin Sleep Med , vol.3 , pp. S7-S10
    • Roth, T.1
  • 2
    • 0030823270 scopus 로고    scopus 로고
    • Prevalence, burden, and treatment of insomnia in primary care
    • Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997; 154:1417-23.
    • (1997) Am J Psychiatry , vol.154 , pp. 1417-1423
    • Simon, G.E.1    VonKorff, M.2
  • 3
    • 67349228757 scopus 로고    scopus 로고
    • Insomnia and its relationship to healthcare utilization, work absenteeism, productivity and accidents
    • Daley M, Morin CM, LeBlanc M et al. Insomnia and its relationship to healthcare utilization, work absenteeism, productivity and accidents. Sleep Med. 2009; 10:427-38.
    • (2009) Sleep Med , vol.10 , pp. 427-438
    • Daley, M.1    Morin, C.M.2    LeBlanc, M.3
  • 4
    • 79951665856 scopus 로고    scopus 로고
    • The societal costs of insomnia
    • Wade AG. The societal costs of insomnia. Neuropsychiatr Dis Treat. 2011; 7:1-18.
    • (2011) Neuropsychiatr Dis Treat , vol.7 , pp. 1-18
    • Wade, A.G.1
  • 5
    • 62349100214 scopus 로고    scopus 로고
    • The natural history of insomnia: A population-based 3-year longitudinal study
    • Morin CM, Bélanger L, LeBlanc M et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009; 169:447-53.
    • (2009) Arch Intern Med , vol.169 , pp. 447-453
    • Morin, C.M.1    Bélanger, L.2    LeBlanc, M.3
  • 7
    • 85067747233 scopus 로고    scopus 로고
    • American Psychiatric Association. Highlights to changes from DSM-IV-TR to DSM-5. www.psychiatry.org/File%20Library/Practice/DSM/DSM-5/Changes-from-DSM-IV-TR-to-DSM-5.pdf (accessed 2013 Jun 11).
    • Highlights to Changes from DSM-IV-TR to DSM-5
  • 8
    • 40749126697 scopus 로고    scopus 로고
    • Insomnia and comorbid psychiatric disorders
    • Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med. 2007; 8(suppl 4):S15-20.
    • (2007) Sleep Med , vol.8 , pp. S15-S20
    • Riemann, D.1
  • 9
    • 65949116784 scopus 로고    scopus 로고
    • Update on sleep and psychiatric disorders
    • Sateia MJ. Update on sleep and psychiatric disorders. Chest. 2009; 135:1370-9.
    • (2009) Chest , vol.135 , pp. 1370-1379
    • Sateia, M.J.1
  • 12
    • 39749190543 scopus 로고    scopus 로고
    • Patterns of quetiapine use in psychiatric inpatients: An examination of off-label use
    • Philip NS, Mello K, Carpenter LL et al. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry. 2008; 20:15-20.
    • (2008) Ann Clin Psychiatry , vol.20 , pp. 15-20
    • Philip, N.S.1    Mello, K.2    Carpenter, L.L.3
  • 13
    • 85067769970 scopus 로고    scopus 로고
    • Quetiapine
    • Greenwood Village, CO: Thomson Reuters (Healthcare). Updated periodically
    • Quetiapine. In: Drugdex System. Greenwood Village, CO: Thomson Reuters (Healthcare). Updated periodically.
    • Drugdex System
  • 14
    • 62449321971 scopus 로고    scopus 로고
    • Selective histamine H1 antagonism: Novel hypnotic and pharmacologic actions challenge classical notions of antihistamines
    • Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008; 13:1027-38.
    • (2008) CNS Spectr , vol.13 , pp. 1027-1038
    • Stahl, S.M.1
  • 15
    • 55349132739 scopus 로고    scopus 로고
    • Clinical guideline for the evaluation and management of chronic insomnia in adults
    • Schutte-Rodin S, Broch L, Buysse D et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4:487-504.
    • (2008) J Clin Sleep Med , vol.4 , pp. 487-504
    • Schutte-Rodin, S.1    Broch, L.2    Buysse, D.3
  • 16
    • 84856402909 scopus 로고    scopus 로고
    • Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison
    • Reeves R. Guideline, education, and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison. J Correct Health Care. 2012; 18:45-52.
    • (2012) J Correct Health Care , vol.18 , pp. 45-52
    • Reeves, R.1
  • 19
    • 11144334174 scopus 로고    scopus 로고
    • Drugs used to treat insomnia in 2002: Regulatory-based rather than evidence-based medicine
    • Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep. 2004; 27:1441-2.
    • (2004) Sleep , vol.27 , pp. 1441-1442
    • Walsh, J.K.1
  • 20
    • 85067771255 scopus 로고    scopus 로고
    • Thomson Reuters Micromedex Clinical Evidence Solutions. http://thomsonreuters.com/products-services/healthcare/healthcare-products/clinical-deci-support/micromedex-clinical-evidence-sols/med-safety-solutions/red-book (accessed 2013 Apr 4).
  • 21
    • 1842774440 scopus 로고    scopus 로고
    • Sleep-promoting properties of quetiapine in healthy subjects
    • Cohrs S, Rodenbeck A, Guan Z et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology. 2004; 174:421-9.
    • (2004) Psychopharmacology , vol.174 , pp. 421-429
    • Cohrs, S.1    Rodenbeck, A.2    Guan, Z.3
  • 22
    • 38349187275 scopus 로고    scopus 로고
    • Quetiapine in primary insomnia: A pilot study
    • Letter
    • Wiegand MH, Landry F, Brückner T et al. Quetiapine in primary insomnia: a pilot study. Psychopharmacology. 2008; 196:337-8. Letter.
    • (2008) Psychopharmacology , vol.196 , pp. 337-338
    • Wiegand, M.H.1    Landry, F.2    Brückner, T.3
  • 23
    • 77954527766 scopus 로고    scopus 로고
    • Quetiapine for primary insomnia: A double blind, randomized controlled trial
    • Tassniyom K, Paholpak S, Tassniyom S et al. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thai. 2010; 93:729-34.
    • (2010) J Med Assoc Thai , vol.93 , pp. 729-734
    • Tassniyom, K.1    Paholpak, S.2    Tassniyom, S.3
  • 24
    • 33746904416 scopus 로고    scopus 로고
    • Quetiapine augmentation in treatment-resistant depression: A naturalistic study
    • Šagud M, Mihaljević-Peleš A, Mück-Šeler D et al. Quetiapine augmentation in treatment-resistant depression: a naturalistic study. Psychopharmacology. 2006; 187:511-4.
    • (2006) Psychopharmacology , vol.187 , pp. 511-514
    • Šagud, M.1    Mihaljević-Peleš, A.2    Mück-Šeler, D.3
  • 25
    • 54449093654 scopus 로고    scopus 로고
    • A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    • Garakani A, Martinez JM, Marcus S et al. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Int Clin Psychopharm. 2008; 23:269-75.
    • (2008) Int Clin Psychopharm , vol.23 , pp. 269-275
    • Garakani, A.1    Martinez, J.M.2    Marcus, S.3
  • 26
    • 54049124418 scopus 로고    scopus 로고
    • Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep
    • Endicott J, Paulsson B, Gustafsson U et al. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep. J Affect Disord. 2008; 111:306-19.
    • (2008) J Affect Disord , vol.111 , pp. 306-319
    • Endicott, J.1    Paulsson, B.2    Gustafsson, U.3
  • 27
    • 77649138108 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)
    • McElroy SL, Weisler RH, Chang W et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010; 71:163-74.
    • (2010) J Clin Psychiatry , vol.71 , pp. 163-174
    • McElroy, S.L.1    Weisler, R.H.2    Chang, W.3
  • 28
    • 23644433193 scopus 로고    scopus 로고
    • Quetiapine for insomnia in Parkinson disease: Results from an open-label trial
    • Juri C, Chaná P, Tapia J et al. Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol. 2005; 28:185-7.
    • (2005) Clin Neuropharmacol , vol.28 , pp. 185-187
    • Juri, C.1    Chaná, P.2    Tapia, J.3
  • 29
    • 66749092411 scopus 로고    scopus 로고
    • Quetiapine for tamoxifen-induced insomnia in women with breast cancer
    • Pasquini M, Speca A, Biondi M. Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics. 2009; 50:159-61.
    • (2009) Psychosomatics , vol.50 , pp. 159-161
    • Pasquini, M.1    Speca, A.2    Biondi, M.3
  • 30
    • 57649131067 scopus 로고    scopus 로고
    • Quetiapine in the treatment of sleep disturbances associated with addictive conditions: A retrospective study
    • Terán A, Majadas S, Galan J. Quetiapine in the treatment of sleep disturbances associated with addictive conditions: a retrospective study. Subst Use Misuse. 2008; 43:2169-71.
    • (2008) Subst Use Misuse , vol.43 , pp. 2169-2171
    • Terán, A.1    Majadas, S.2    Galan, J.3
  • 31
    • 18144390227 scopus 로고    scopus 로고
    • Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: Comparison of middle-aged and older adults
    • Yamashita H, Mori K, Nagao M et al. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults. Am J Geriatr Psychiatry. 2005; 13:377-84.
    • (2005) Am J Geriatr Psychiatry , vol.13 , pp. 377-384
    • Yamashita, H.1    Mori, K.2    Nagao, M.3
  • 32
    • 33751103685 scopus 로고    scopus 로고
    • Night locomotor activity and quality of sleep in quetiapine-treated patients with depression
    • Todder D, Caliskan S, Baune BT. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. J Clin Psychopharmacol. 2006; 26:638-42.
    • (2006) J Clin Psychopharmacol , vol.26 , pp. 638-642
    • Todder, D.1    Caliskan, S.2    Baune, B.T.3
  • 33
    • 33846581048 scopus 로고    scopus 로고
    • Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression
    • Baune BT, Caliskan S, Todder D. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Hum Psychopharmacol Clin Exp. 2007; 22:1-9.
    • (2007) Hum Psychopharmacol Clin Exp , vol.22 , pp. 1-9
    • Baune, B.T.1    Caliskan, S.2    Todder, D.3
  • 34
    • 68649100415 scopus 로고    scopus 로고
    • Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients
    • Cates ME, Jackson CW, Feldman JM et al. Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Ment Health J. 2009; 45:251-4.
    • (2009) Community Ment Health J , vol.45 , pp. 251-254
    • Cates, M.E.1    Jackson, C.W.2    Feldman, J.M.3
  • 35
    • 51149115322 scopus 로고    scopus 로고
    • Low-dose quetiapine is not a benign sedative-hypnotic agent
    • Gugger JJ, Cassagnol M. Low-dose quetiapine is not a benign sedative-hypnotic agent. Am J Addict. 2008; 17:454-5.
    • (2008) Am J Addict , vol.17 , pp. 454-455
    • Gugger, J.J.1    Cassagnol, M.2
  • 36
    • 84860991804 scopus 로고    scopus 로고
    • Safety of low doses of quetiapine when used for insomnia
    • Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother. 2012; 46:718-22.
    • (2012) Ann Pharmacother , vol.46 , pp. 718-722
    • Coe, H.V.1    Hong, I.S.2
  • 38
    • 80051966985 scopus 로고    scopus 로고
    • IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2011. www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII-Medicines-in-U.S-Report-2011.pdf (accessed 2012 Jun 29).
    • The Use of Medicines in the United States: Review of 2011
  • 39
    • 77649095652 scopus 로고    scopus 로고
    • Is Seroquel developing an illicit reputation for misuse/abuse?
    • Sansone RA, Sansone LA. Is Seroquel developing an illicit reputation for misuse/abuse? Psychiatry. 2010; 7:13-6.
    • (2010) Psychiatry , vol.7 , pp. 13-16
    • Sansone, R.A.1    Sansone, L.A.2
  • 40
    • 33846534295 scopus 로고    scopus 로고
    • Intravenous quetiapine-cocaine use ("Q-ball")
    • Waters BM, Joshi KG. Intravenous quetiapine-cocaine use ("Q-ball"). Am J Psychiatry. 2007; 164:173-4.
    • (2007) Am J Psychiatry , vol.164 , pp. 173-174
    • Waters, B.M.1    Joshi, K.G.2
  • 42
    • 80051848902 scopus 로고    scopus 로고
    • Off-label drug use and promotion: Balancing public health goals and commercial speech
    • Kesselheim AS. Off-label drug use and promotion: balancing public health goals and commercial speech. Am J Law Med. 2011; 37:225-57.
    • (2011) Am J Law Med , vol.37 , pp. 225-257
    • Kesselheim, A.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.